Banner Alzheimer's Institute (BAI) is home to international leaders in Alzheimer's disease research and care. Their goals are to end Alzheimer's without losing a generation, establish a new national standard of dementia care, and forge new models of collaboration in biomedical research. They have developed strategically focused programs to accomplish each of these goals.
Meet our leaders::
Eric M. Reiman, MD
Executive Director, Banner Alzheimer's Institute & CEO, Banner Research
Professor of Psychiatry, University of Arizona
University Professor of Neuroscience, Arizona State University
Clinical Director of Neurogenomics, Translational Genomics Research Institute
Director, Arizona Alzheimer's Consortium
Dr. Reiman is executive director of the Banner Alzheimer's Institute, chief executive officer of Banner Research, clinical director of Neurogenomics at the Translational Genomics Research Institute, professor of Psychiatry at the University of Arizona, university professor of Neuroscience at Arizona State University, and director of the Arizona Alzheimer's Consortium.
Dr. Reiman's research interests include brain imaging, genomics, the unusually early detection and tracking of Alzheimer's disease (AD), and the accelerated evaluation of AD prevention therapies. He is also interested in strategies to establish a new standard of dementia care for patients and family caregivers in the emerging health care financing system and the development of new models of collaboration in biomedical research. He is an author of more than 250 publications and a principal investigator of several NIH grants.
Dr. Reiman and his BAI colleagues, Pierre Tariot and Jessica Langbaum, lead the Alzheimer's Prevention Initiative (API), which has helped to launch a new era in Alzheimer's prevention research. He is a recipient of the Potamkin Prize for his pioneering contributions to the field.
Pierre N. Tariot,
Director, Banner Alzheimer's Institute
Research Professor, University of Arizona College of Medicine
Dr. Tariot is a Phi Beta Kappa graduate of Amherst College who attended the University of Rochester School of Medicine. He completed residencies in Internal Medicine and Psychiatry at the University of Wisconsin in Madison, Wisc., and is board certified in both specialties, with added qualifications in geriatrics. He served as a Fellow at the Intramural Research Program of the National Institute of Mental Health.
In 1986, he joined the faculty of the University of Rochester Medical Center, achieving the rank of Professor of Psychiatry, Medicine, Neurology, and Aging and Developmental Biology. While there, he served as Director of the Memory Disorders Clinic, Director of Psychiatry at Monroe Community Hospital, and Director of the University of Rochester component of the NIA-funded Alzheimer's Disease Cooperative Study.
Since 2006, he has been at the Banner Alzheimer's Institute, where he serves as Director. Dr. Tariot has investigated, and lectured extensively on multiple aspects of diagnosis, therapy and prevention of Alzheimer's disease, and has published over 250 papers on these topics. He has served as author for several studies that have led to FDA approval of treatments for Alzheimer's disease. He has led efforts to refine our ability to measure behavioral changes in dementia and contributed to large multicenter trials of a range of treatments for these neuropsychiatric features. He has participated in efforts to identify novel therapies for Alzheimer's as well as novel clinical trials methods for studying them.
Together with his colleague and friend, Eric Reiman, he serves as co-director of the Alzheimer's Prevention Initiative, an NIH-funded international program to study experimental therapies that may delay or even prevent the symptoms of Alzheimer's in people at high imminent risk.
Dr. Tariot leads the Banner "Dementia Care Initiative," a program designed to demonstrate the clinical and cost-effectiveness of standardized care for persons with dementia in a large health care system.
He now has an appointment as Research Professor of Psychiatry at the University of Arizona College of Medicine. He is a member of the American College of Neuropsychopharmacology.
He has earned several awards for his research, including the American Geriatrics Society New Investigator Award for Neuroscience, an NIMH Geriatric Mental Health Academic Award, the 2005 UCLA Turken Award, and was named the 2012 Geriatrician of the Year by the Arizona Geriatrics Society.
Dr. Tariot's research affiliations include the National Institute of Mental Health, the New York State Department of Health, Arizona Department of Health, the National Institute on Aging, the Institute for Mental Health Research, and the Alzheimer's Association.
William Burke, MD
Stead Family Memory Center
Dr. William Burke is the Director of the Stead Family Memory
Center and a board-certified physician in geriatric psychiatry. Dr.
Burke received his medical degree from the University of Nebraska
Medical Center in Omaha, NE where he also completed an internship
in Internal Medicine. He performed his residency in Psychiatry at
Barnes Hospital and Washington University Medical School in St.
Louis, MO. He received additional post-graduate training at the
Alzheimer Disease Research Center at Washington University while
also studying psychiatric epidemiology.
Dr. Burke spent more than 25 years at the University of Nebraska Medical Center where he was the Anna O. Stake Professor of Psychiatry, the Vice-Chair for Research and Director of the Psychopharmacology Research Center at UNMC. His research interests have focused on evaluation of potential new treatments for Alzheimer disease, delirium and depression with a particular interest in disease prevention. He has published widely including scientific articles, book chapters and abstracts. Dr. Burke has been repeatedly cited as a Castle Connolly/U.S. News "Top Doctor" and in "Best Doctors in America."
Jessica Langbaum, PhD
Principal Scientist, Banner Alzheimer's Institute
Associate Director, Alzheimer's Prevention Initiative
Dr. Langbaum, a principal scientist at Banner Alzheimer's Institute, earned a bachelor's degree in neuroscience and psychology with high honors from Oberlin College in Oberlin, Ohio, and a Ph.D. in psychiatric epidemiology from the Johns Hopkins University. Her doctoral studies focused on cognition and aging in older adults, in particular, cognitive training interventions for delaying or preventing cognitive and functional decline. She completed a post-doctoral research fellowship in brain imaging and Alzheimer's disease at Banner Alzheimer's Institute. She is actively involved here in research activities focusing on the use of brain imaging for studying the earliest evidence of Alzheimer's and on the design and execution of presymptomatic Alzheimer's treatment trials. Langbaum has published papers in leading scientific journals on cognitive training, brain imaging and Alzheimer's disease.